{
  "trial_id": "NCT01281956",
  "overall_assessment": "likely_ineligible",
  "inclusion": [
    {
      "criterion": "Enrolled in protocol 01-N-0139",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "Age 18 to 65",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "Localization-related epilepsy diagnosed by standard clinical criteria that has not responded to treatment with up to two standard antiepileptic drugs either sequentially or in combination.",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Patients must be able to provide informed consent.",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "Patients must be able to remain on their baseline AED drugs and doses for the duration of the study",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Patients must be able to use seizure calendars to record seizures throughout the trial.",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "Experiences 4 seizures within a 6-week period",
      "label": "not_met",
      "evidence": ""
    }
  ],
  "exclusion": [
    {
      "criterion": "Pregnancy or lactation",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Women of child-bearing potential and men who are unable or unwilling to take adequate contraceptive precautions, including one of the following: hormonal contraception (birth control pills, injected hormones or vaginal ring); intrauterine device; barrier methods (condom or diaphragm) combined with spermicide; surgical sterilization (hysterectomy, tubal ligation, or vasectomy in a partner",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Current treatment for another significant medical disorder, such as diabetes, or heart disease, or an untreated disorder, that is discovered during the screening examination the participant.",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "An abnormality on clinical laboratory tests, physical examination, EEG or ECG that might increase the risk associated with trial participation or investigational product administration, such as hepatic enzyme elevation greater than twice normal, or hematocrit lower than 30.",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "A level 4 or 5 on the Columbia Suicide Severity Rating Scale rating for symptoms during the last month",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Concomitant treatment with more than 2 AEDs",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "Evidence for a potentially progressive neurologic disorder, such as an astrocytoma",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Use of sublingual lorazepam for seizure clusters more than once per wee",
      "label": "met",
      "evidence": ""
    }
  ],
  "notes": "Patient has a history of severe intellectual disability, CHF, and epilepsy. He has experienced seizures in the past but was able to manage them with medication. However, he recently developed facial twitching and generalized shaking, which required valium to cease seizure activity.",
  "_meta": {
    "topic_id": "9",
    "trial_id": "NCT01281956",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}